Q1 2021

Source filing unavailable

Q1 2021 · —

Revenue

€4.21B

−6.2% vs Q1 2020

Net Income

€248.95M

−11.9% vs Q1 2020

EPS Diluted

€0.85

−10.5% vs Q1 2020

Gross Profit€1,206,657,000−14.5%

Operating Income€474,253,000−14.6%

Operating Cash Flow€207,648,000

Same quarter

Metric	Q1 2021	Q1 2020	Q1 2019	Q1 2018
Revenue	€4.21B	€4.49B	€4.13B	€3.98B
Net Income	€248.95M	€282.72M	€270.75M	€278.56M
EPS Diluted	€0.85	€0.95	€0.88	€0.91

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Fresenius Medical Care AG · CIK 1333141 · Engraved from SEC EDGAR